-
1
-
-
84905675648
-
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
-
[1] Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 506–514, 10.1038/nrgastro.2014.66.
-
(2014)
Nat. Rev. Gastroenterol. Hepatol.
, vol.11
, pp. 506-514
-
-
Hill, C.1
Guarner, F.2
Reid, G.3
Gibson, G.R.4
Merenstein, D.J.5
Pot, B.6
-
2
-
-
84875348375
-
Actual concept of probiotics: is it more functional to science or business?
-
[2] Caselli, M., Cassol, F., Calò, G., Holton, J., Zuliani, G., Gasbarrini, A., Actual concept of probiotics: is it more functional to science or business?. WJG 19 (2013), 1527–1540, 10.3748/wjg.v19.i10.1527.
-
(2013)
WJG
, vol.19
, pp. 1527-1540
-
-
Caselli, M.1
Cassol, F.2
Calò, G.3
Holton, J.4
Zuliani, G.5
Gasbarrini, A.6
-
3
-
-
84881547933
-
Probiotics from research to market: the possibilities, risks and challenges
-
[3] Foligné, B., Daniel, C., Pot, B., Probiotics from research to market: the possibilities, risks and challenges. Curr. Opin. Microbiol. 16 (2013), 284–292, 10.1016/j.mib.2013.06.008.
-
(2013)
Curr. Opin. Microbiol.
, vol.16
, pp. 284-292
-
-
Foligné, B.1
Daniel, C.2
Pot, B.3
-
4
-
-
84875863443
-
An update on the use and investigation of probiotics in health and disease
-
[4] Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., et al. An update on the use and investigation of probiotics in health and disease. Gut 62 (2013), 787–796, 10.1136/gutjnl-2012-302504.
-
(2013)
Gut
, vol.62
, pp. 787-796
-
-
Sanders, M.E.1
Guarner, F.2
Guerrant, R.3
Holt, P.R.4
Quigley, E.M.5
Sartor, R.B.6
-
5
-
-
84908170025
-
Recommendations for probiotic use in humansaupdate
-
[5] Floch, M.H., Recommendations for probiotic use in humansaupdate. Pharmaceuticals 7 (2014), 999–1007, 10.3390/ph7100999.
-
(2014)
Pharmaceuticals
, vol.7
, pp. 999-1007
-
-
Floch, M.H.1
-
6
-
-
7744222428
-
Health care organizations as complex adaptive systems
-
S.S.F. Mick P.D. Shay Jossey-Bass San Francisco
-
[6] Begun, J.W., Zimmerman, B., Dooley, K., Health care organizations as complex adaptive systems. Mick, S.S.F., Shay, P.D., (eds.) Advances in Health Care Organization Theory, 2003, Jossey-Bass, San Francisco.
-
(2003)
Advances in Health Care Organization Theory
-
-
Begun, J.W.1
Zimmerman, B.2
Dooley, K.3
-
7
-
-
0000289608
-
The social psychology of innovation in groups
-
M.A. West J.L. Farr Wiley Chichester, UK
-
[7] West, M.A., The social psychology of innovation in groups. West, M.A., Farr, J.L., (eds.) Innovation and Creativity at Work: Psychological and Organizational Strategies, 1990, Wiley, Chichester, UK, 309–334.
-
(1990)
Innovation and Creativity at Work: Psychological and Organizational Strategies
, pp. 309-334
-
-
West, M.A.1
-
8
-
-
31144438108
-
Innovation in healthcare: a systematic review of recent research
-
[8] Länsisalmi, H., Kivimäki, M., Aalto, P., Ruoranen, R., Innovation in healthcare: a systematic review of recent research. Nurs. Sci. Q. 19 (2006), 66–72, 10.1177/0894318405284129.
-
(2006)
Nurs. Sci. Q.
, vol.19
, pp. 66-72
-
-
Länsisalmi, H.1
Kivimäki, M.2
Aalto, P.3
Ruoranen, R.4
-
9
-
-
80054102456
-
Probiotics for prevention and treatment of diarrhea
-
[9] Guandalini, S., Probiotics for prevention and treatment of diarrhea. J. Clin. Gastroenterol. 45 (2011), S149–S153, 10.1097/MCG.0b013e3182257e98.
-
(2011)
J. Clin. Gastroenterol.
, vol.45
, pp. S149-S153
-
-
Guandalini, S.1
-
10
-
-
84923844582
-
Probiotics for prevention of necrotizing enterocolitis in preterm infants
-
[10] AlFaleh, K., Anabrees, J., Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid. Based Child Health 9 (2014), 584–671, 10.1002/ebch.1976.
-
(2014)
Evid. Based Child Health
, vol.9
, pp. 584-671
-
-
AlFaleh, K.1
Anabrees, J.2
-
11
-
-
81855202739
-
Probiotic and prebiotic claims in Europe: seeking a clear roadmap
-
[11] Guarner, F., Sanders, M.E., Gibson, G., Klaenhammer, T., Cabana, M., Scott, K., et al. Probiotic and prebiotic claims in Europe: seeking a clear roadmap. Br. J. Nutr. 106 (2011), 1765–1767.
-
(2011)
Br. J. Nutr.
, vol.106
, pp. 1765-1767
-
-
Guarner, F.1
Sanders, M.E.2
Gibson, G.3
Klaenhammer, T.4
Cabana, M.5
Scott, K.6
-
12
-
-
84928724733
-
A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union
-
[12] Glanville, J., King, S., Guarner, F., Hill, C., Sanders, M.E., A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union. Nutr. J., 14, 2015, 16, 10.1186/s12937-015-0004-5.
-
(2015)
Nutr. J.
, vol.14
, pp. 16
-
-
Glanville, J.1
King, S.2
Guarner, F.3
Hill, C.4
Sanders, M.E.5
-
13
-
-
84879601489
-
Barriers to innovation in the medical nutrition industry: a quantitative key opinion leader analysis
-
[13] Weenen, T.C., Pronker, E.S., Commandeur, H.R., Claassen, E.H.J.M., Barriers to innovation in the medical nutrition industry: a quantitative key opinion leader analysis. PharmaNutrition 1 (2013), 79–85, 10.1016/j.phanu.2013.04.001.
-
(2013)
PharmaNutrition
, vol.1
, pp. 79-85
-
-
Weenen, T.C.1
Pronker, E.S.2
Commandeur, H.R.3
Claassen, E.H.J.M.4
-
14
-
-
0032669294
-
Barriers to innovation for SMEs in a small less developed country (Cyprus)
-
[14] Hadjimanolis, A., Barriers to innovation for SMEs in a small less developed country (Cyprus). Technovation 570 (1999), 34–36, 10.1016/S0166-4972(99)00034-6.
-
(1999)
Technovation
, vol.570
, pp. 34-36
-
-
Hadjimanolis, A.1
-
15
-
-
84930381579
-
Adopting Health Apps, What's Hindering Doctors and Patients?
-
[15] Dehzad, F., Hilhorst, C., de Bie, C., Claassen, E., Adopting Health Apps, What's Hindering Doctors and Patients?. Health 6 (2014), 2204–2217, 10.4236/health.2014.616256.
-
(2014)
Health
, vol.6
, pp. 2204-2217
-
-
Dehzad, F.1
Hilhorst, C.2
de Bie, C.3
Claassen, E.4
-
16
-
-
84943154656
-
Innovation paradox in vaccine target selection
-
Erasmus University Rotterdam Rotterdam, The Netherlands Retrieved from:.
-
[16] Pronker, E.S., Innovation paradox in vaccine target selection. Doctoral Thesis, 2013, Erasmus University Rotterdam, Rotterdam, The Netherlands Retrieved from: http://hdl.handle.net/1765/1.
-
(2013)
Doctoral Thesis
-
-
Pronker, E.S.1
-
17
-
-
84982214434
-
-
Valorisation at the EUR. In P.A.G. van Bergeijk & L. Johnson (eds), Social impact @ sciences: The end of the ivory tower? (pp.). Retrieved from:.
-
[17] Claassen E. Valorisation at the EUR. In P.A.G. van Bergeijk & L. Johnson (eds), Social impact @ sciences: The end of the ivory tower? (pp. 30–39). Retrieved from: http://www.iss.nl/fileadmin/ASSETS/iss/Documents/Academic_publications/Social_impact_sciences_conference_book_Oct2014.pdf.
-
-
-
Claassen, E.1
-
18
-
-
84982214430
-
-
Eleven International Publishing
-
[18] Verschuren, P., Doorewaard, H., Mellion, M.J., Designing a Research Project, vol. 2, 2010, Eleven International Publishing.
-
(2010)
Designing a Research Project
, vol.2
-
-
Verschuren, P.1
Doorewaard, H.2
Mellion, M.J.3
-
19
-
-
60549089819
-
Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance
-
[19] Van Baarlen, P., Troost, F.J., van Hemert, S., van der Meer, C., de Vos, W.M., de Groot, P.J., et al. Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. PNAS 106 (2009), 2371–2376, 10.1073/pnas.0809919106.
-
(2009)
PNAS
, vol.106
, pp. 2371-2376
-
-
Van Baarlen, P.1
Troost, F.J.2
van Hemert, S.3
van der Meer, C.4
de Vos, W.M.5
de Groot, P.J.6
-
20
-
-
40049085247
-
Probiotic foods and drugs: impact of US regulatory status on design of clinical trials
-
[20] Hibberd, P.L., Davidson, L., Probiotic foods and drugs: impact of US regulatory status on design of clinical trials. Clin. Infect. Dis. 46 (2008), S137–S140, 10.1086/523321.
-
(2008)
Clin. Infect. Dis.
, vol.46
, pp. S137-S140
-
-
Hibberd, P.L.1
Davidson, L.2
-
21
-
-
84866938865
-
Why the European Food Safety Authority was right to reject health claims for probiotics
-
[21] Katan, M.B., Why the European Food Safety Authority was right to reject health claims for probiotics. Benef. Microbes 3 (2012), 85–89.
-
(2012)
Benef. Microbes
, vol.3
, pp. 85-89
-
-
Katan, M.B.1
-
22
-
-
85027927719
-
Enterotypes of the human gut microbiome
-
[22] Arumugam, M., Raes, J., Pelletier, E., Le, P., aslier, D., Yamada, T., Mende, D.R., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180, 10.1038/nature09944.
-
(2011)
Nature
, vol.473
, pp. 174-180
-
-
Arumugam, M.1
Raes, J.2
Pelletier, E.3
Le, P.4
aslier, D.5
Yamada, T.6
Mende, D.R.7
-
23
-
-
84866146940
-
Diversity, stability and resilience of the human gut microbiota
-
[23] Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230, 10.1038/nature11550.
-
(2012)
Nature
, vol.489
, pp. 220-230
-
-
Lozupone, C.A.1
Stombaugh, J.I.2
Gordon, J.I.3
Jansson, J.K.4
Knight, R.5
-
24
-
-
84885759885
-
Probiotics finding the right regulatory balance
-
[24] Hoffmann, D.E., Fraser-Liggett, C.M., Palumbo, F.B., Ravel, J., Rothenberg, K.H., Rowthorn, V., Probiotics finding the right regulatory balance. Science 342 (2013), 314–315, 10.1126/science.1244656.
-
(2013)
Science
, vol.342
, pp. 314-315
-
-
Hoffmann, D.E.1
Fraser-Liggett, C.M.2
Palumbo, F.B.3
Ravel, J.4
Rothenberg, K.H.5
Rowthorn, V.6
-
25
-
-
84856257307
-
Scientific substantiation of health claims in the EU
-
[25] Flynn, A., Scientific substantiation of health claims in the EU. PNAS 71 (2012), 120–126, 10.1017/s0029665111003168.
-
(2012)
PNAS
, vol.71
, pp. 120-126
-
-
Flynn, A.1
-
26
-
-
84923351295
-
Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization
-
[26] Arora, M., Baldi, A., Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization. Indian J. Med. Microbiol. 33 (2015), 2–10, 10.4103/0255-0857.150868.
-
(2015)
Indian J. Med. Microbiol.
, vol.33
, pp. 2-10
-
-
Arora, M.1
Baldi, A.2
-
27
-
-
84878146489
-
Lactobacillus plantarum passage through an oro-gastro-intestinal tract simulator: carrier matrix effect and transcriptional analysis of genes associated to stress and probiosis
-
[27] Bove, P., Russo, P., Capozzi, V., Gallone, A., Spano, G., Fiocco, D., Lactobacillus plantarum passage through an oro-gastro-intestinal tract simulator: carrier matrix effect and transcriptional analysis of genes associated to stress and probiosis. Microbiol. Res. 168 (2013), 351–359, 10.1016/j.micres.2013.01.004.
-
(2013)
Microbiol. Res.
, vol.168
, pp. 351-359
-
-
Bove, P.1
Russo, P.2
Capozzi, V.3
Gallone, A.4
Spano, G.5
Fiocco, D.6
-
28
-
-
84857060451
-
Legal status of microbial food cultures in the European Union: an overview
-
[28] Herody, C., Soyeux, Y., Hansen, E.B., Gillies, K., Legal status of microbial food cultures in the European Union: an overview. EFFL, 258, 2010.
-
(2010)
EFFL
, vol.258
-
-
Herody, C.1
Soyeux, Y.2
Hansen, E.B.3
Gillies, K.4
-
29
-
-
17044368826
-
The primacy of self-regulation in health promotion
-
[29] Bandura, A., The primacy of self-regulation in health promotion. Appl. Psychol. 54 (2005), 245–254, 10.1111/j.1464-0597.2005.00208.x.
-
(2005)
Appl. Psychol.
, vol.54
, pp. 245-254
-
-
Bandura, A.1
-
30
-
-
25444531717
-
Viability of bifidobacteria in commercial yogurt products in North Carolina
-
[30] Carr, J.P., Ibrahim, S.A., Viability of bifidobacteria in commercial yogurt products in North Carolina. Milchwissenschaft 60 (2005), 414–416.
-
(2005)
Milchwissenschaft
, vol.60
, pp. 414-416
-
-
Carr, J.P.1
Ibrahim, S.A.2
-
31
-
-
84875024576
-
Failures in Functional Foods: 10 Key Case Studies & 10 Key Lessons
-
New Nutrition Business London, UK
-
[31] Mellentin, J., Failures in Functional Foods: 10 Key Case Studies & 10 Key Lessons. 2007, New Nutrition Business, London, UK.
-
(2007)
-
-
Mellentin, J.1
-
32
-
-
84920969881
-
The administration of probiotics and synbiotics in immune compromised adults: is it safe?
-
[32] Van den Nieuwboer, M., Brummer, R.J., Guarner, F., Morelli, L., Cabana, M., Claassen, E., The administration of probiotics and synbiotics in immune compromised adults: is it safe?. Benef. Microbes 6 (2014), 3–17, 10.3920/BM2014.0079.
-
(2014)
Benef. Microbes
, vol.6
, pp. 3-17
-
-
Van den Nieuwboer, M.1
Brummer, R.J.2
Guarner, F.3
Morelli, L.4
Cabana, M.5
Claassen, E.6
-
33
-
-
84894356563
-
Probiotic and synbiotic safety in infants under two years of age
-
[33] Van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F., Brummer, R.J., Probiotic and synbiotic safety in infants under two years of age. Benef. Microbes 5 (2014), 45–60, 10.3920/BM2013.0046.
-
(2014)
Benef. Microbes
, vol.5
, pp. 45-60
-
-
Van den Nieuwboer, M.1
Claassen, E.2
Morelli, L.3
Guarner, F.4
Brummer, R.J.5
-
34
-
-
84937519639
-
Probiotics for weight loss: a systematic review and meta-analysis
-
[34] Park, S., Bae, J.H., Probiotics for weight loss: a systematic review and meta-analysis. Nutr. Res. 35 (2015), 566–575, 10.1016/j.nutres.2015.05.008.
-
(2015)
Nutr. Res.
, vol.35
, pp. 566-575
-
-
Park, S.1
Bae, J.H.2
-
35
-
-
85055343018
-
Scientific opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
-
[35] EFSA Panel on Dietetic Products, Nutrition and Allergies NDA, Scientific opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J., 8, 2010, 1763.
-
(2010)
EFSA J.
, vol.8
, pp. 1763
-
-
EFSA Panel on Dietetic Products1
Nutrition and Allergies NDA2
-
36
-
-
84982193193
-
-
Health Canada, Probiotics. Retrieved from:.
-
[36] Health Canada, Probiotics, (2012). Retrieved from: http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=probio&lang=eng.
-
(2012)
-
-
-
37
-
-
84886717096
-
Probiotics and prebiotics: health claim substantiation
-
[37] Salminen, S., Van Loveren, H., Probiotics and prebiotics: health claim substantiation. Microb. Ecol. Health Dis., 2012, 23, 10.3402/mehd.v23i0.18568.
-
(2012)
Microb. Ecol. Health Dis.
, pp. 23
-
-
Salminen, S.1
Van Loveren, H.2
-
38
-
-
84928266303
-
A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe
-
[38] Miquel, S., Beaumont, M., Martín, R., Langella, P., Braesco, V., Thomas, M., A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb. Cell Fact., 14, 2015, 48, 10.1186/s12934-015-0229-1.
-
(2015)
Microb. Cell Fact.
, vol.14
, pp. 48
-
-
Miquel, S.1
Beaumont, M.2
Martín, R.3
Langella, P.4
Braesco, V.5
Thomas, M.6
|